Gene: NATD1
Official Full Name: N-acetyltransferase domain containing 1provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21059 | NATD1 Knockout cell line (HeLa) | Human | NATD1 | 1:3~1:6 | Negative | Online Inquiry |
KO21060 | NATD1 Knockout cell line (HCT 116) | Human | NATD1 | 1:2~1:4 | Negative | Online Inquiry |
KO21061 | NATD1 Knockout cell line (HEK293) | Human | NATD1 | 1:3~1:6 | Negative | Online Inquiry |
KO21062 | NATD1 Knockout cell line (A549) | Human | NATD1 | 1:3~1:4 | Negative | Online Inquiry |
NATD1 Gene Knockout Cell Lines are genetically engineered cellular models that have undergone precise genome editing to disrupt the NATD1 gene. This targeted knockout serves as an invaluable tool for researchers aiming to elucidate the functional roles of NATD1 in various biological processes, such as cellular metabolism, stress response, and disease mechanisms. By removing the native expression of this gene, scientists can observe subsequent effects on cellular pathways, thereby gaining insight into the physiological significance of NATD1 in both normal and pathological states.
The key functions of these cell lines stem from the systematic approach to gene editing, often utilizing CRISPR-Cas9 technology or similar genome-editing platforms. Upon disruption of NATD1, researchers can investigate alterations in gene expression profiles, metabolic shifts, and other cellular characteristics relative to wild-type cell lines. This enables comprehensive analyses of NATD1's contributions to various cellular phenotypes, enhancing understanding of its role in processes like apoptosis, proliferation, and immune responses.
Scientifically, NATD1 Gene Knockout Cell Lines hold significant value in both molecular biology research and clinical applications. They provide essential models for drug discovery, genetic research, disease modeling, and testing therapies targeting pathways influenced by NATD1. Through these applications, researchers can establish correlations between NATD1 and conditions such as cancer or metabolic disorders, ultimately contributing to the development of more effective treatments.
What sets our NATD1 Gene Knockout Cell Lines apart is their validated knockout efficiency and phenotypic stability, ensuring that researchers can trust the models for reproducible results. Furthermore, they are compatible with a wide range of assays and downstream applications, making them versatile tools in the research setting. Our commitment to quality and precision in genetic engineering guarantees that these cell lines are among the best in the market, streamlining the research process for scientists.
In addition to our robust product offering, our company boasts extensive expertise in cell line development and genetic engineering, allowing us to support researchers with unparalleled technical guidance and service. By choosing NATD1 Gene Knockout Cell Lines, you are investing in robust tools designed to advance scientific discovery and clinical research effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.